BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24503588)

  • 1. EUROPLAN: a project to support the development of national plans on rare diseases in Europe.
    Taruscio D; Gentile AE; De Santis M; Ferrelli RM; Posada de la Paz M; Hens M; Huizer J; Fregonese L; Stefanov R; Bottarelli V; Weinman A; Le Cam Y; Gavhed D; Mincarone P; Bushby K; Frazzica RG; Donati C; Vittozzi L; Jessop E
    Public Health Genomics; 2013; 16(6):278-87. PubMed ID: 24503588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National plans and strategies on rare diseases in Europe.
    Taruscio D; Vittozzi L; Stefanov R
    Adv Exp Med Biol; 2010; 686():475-91. PubMed ID: 20824461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the usability of EUCERD core indicators for rare diseases.
    Ferrelli RM; De Santis M; Gentile AE; Taruscio D
    Ann Ist Super Sanita; 2015; 51(4):342-5. PubMed ID: 26783222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European union policy in the field of rare diseases.
    Montserrat Moliner A; Waligóra J
    Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans.
    Taruscio D; Arriola L; Baldi F; Barisic I; Bermejo-Sánchez E; Bianchi F; Calzolari E; Carbone P; Curran R; Garne E; Gatt M; Latos-Bieleńska A; Khoshnood B; Irgens L; Mantovani A; Martínez-Frías ML; Neville A; Rißmann A; Ruggeri S; Wellesley D; Dolk H
    Public Health Genomics; 2014; 17(2):115-23. PubMed ID: 24714026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hungarian national plan and strategy for rare diseases].
    Kosztolányi G
    Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy.
    Busani L; Creti R; Fabbro E; Prestinaci F; Pantosti A; Marella AM; Brusaferro S; Sabbatucci M
    Chemotherapy; 2024; 69(1):56-64. PubMed ID: 37673044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities - a qualitative study.
    Rosenkötter N; Clemens T; Sørensen K; Brand H
    BMC Public Health; 2013 Nov; 13():1074. PubMed ID: 24225055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys.
    Joas A; Knudsen LE; Kolossa-Gehring M; Sepai O; Casteleyn L; Schoeters G; Angerer J; Castaño A; Aerts D; Biot P; Horvat M; Bloemen L; Reis MF; Lupsa IR; Katsonouri A; Cerna M; Berglund M; Crettaz P; Rudnai P; Halzlova K; Mulcahy M; Gutleb AC; Fischer ME; Becher G; Fréry N; Jensen G; Van Vliet L; Koch HM; Den Hond E; Fiddicke U; Esteban M; Exley K; Schwedler G; Seiwert M; Ligocka D; Hohenblum P; Kyrtopoulos S; Botsivali M; DeFelip E; Guillou C; Reniero F; Grazuleviciene R; Veidebaum T; Mørck TA; Nielsen JK; Jensen JF; Rivas TC; Sanchez J; Koppen G; Smolders R; Kozepesy S; Hadjipanayis A; Krskova A; Mannion R; Jakubowski M; Fucic JA; Pereira-Miguel J; Gurzau AE; Jajcaj M; Mazej D; Tratnik JS; Lehmann A; Larsson K; Dumez B; Joas R
    Environ Res; 2015 Aug; 141():42-57. PubMed ID: 25526891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of Personalized Medicine landscape and policies in the European Union.
    Beccia F; Hoxhaj I; Castagna C; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
    Eur J Public Health; 2022 Nov; 32(6):844-851. PubMed ID: 36305782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy on palliative care in the WHO European region: an overview of progress since the Council of Europe's (2003) recommendation 24.
    Woitha K; Carrasco JM; Clark D; Lynch T; Garralda E; Martin-Moreno JM; Centeno C
    Eur J Public Health; 2016 Apr; 26(2):230-5. PubMed ID: 26545804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health systems, quality of health care, and translational cancer research: the role of the Istituto Superiore Sanità - Rome.
    Ricciardi W
    Tumori; 2015; 101 Suppl 1():S67-8. PubMed ID: 27096278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDH-NET: a South-North-South collaboration to build sustainable research capacities on social determinants of health in low- and middle-income countries.
    Cash-Gibson L; Guerra G; Salgado-de-Snyder VN
    Health Res Policy Syst; 2015 Oct; 13():45. PubMed ID: 26490263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Commission activities in eHealth.
    Olsson S; Lymberis A; Whitehouse D
    Int J Circumpolar Health; 2004 Dec; 63(4):310-6. PubMed ID: 15709306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.